Literature DB >> 9070352

Tissue-specific bioenergetic effects and increased enzymatic activities following acute sublethal peroral exposure to cyanide in the mallard duck.

J Ma1, C A Pritsos.   

Abstract

Protection of wildlife and in particular migratory birds, which are protected by the Migratory Bird Treaty Act, from cyanide waste in and around gold mining operations is an important environmental issue. We have investigated the bioenergetic effects of sublethal peroral cyanide exposure using the mallard duck (Anus platyrhynchos) as a model migratory bird. At cyanide concentrations well below levels considered safe by the mining industry and some regulatory agencies (50 ppm weak acid dissociable (WAD) cyanide) significant depletions of heart, liver, and brain tissue ATP levels were observed. Tissue ATP levels were restored to normal by 24 hr postexposure. Rhodanese and 3-mercaptopyruvate sulfurtransferase activities were determined in these tissues both for basal activity and post-cyanide exposure. Only brain tissue showed increased enzymatic activity following cyanide exposure, suggesting tissue-specific regulation of these enzymatic activities. These studies suggest that 50 ppm WAD cyanide is not a safe level of cyanide in water where avian wildlife exposure can occur.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070352     DOI: 10.1006/taap.1996.8045

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  2 in total

1.  High levels of activity of bats at gold mining water bodies: implications for compliance with the International Cyanide Management Code.

Authors:  Stephen R Griffiths; David B Donato; Graeme Coulson; Linda F Lumsden
Journal:  Environ Sci Pollut Res Int       Date:  2014-02-25       Impact factor: 4.223

2.  Histopathological alterations in spleen of freshwater fish Cyprinus carpio exposed to sublethal concentration of sodium cyanide.

Authors:  M David; R M Kartheek
Journal:  Open Vet J       Date:  2015-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.